Immediate Impact
93 standout
Citing Papers
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
2023 Standout
Heart failure drug treatment
2019 Standout
Works of Daniel Benatar being referenced
Pioglitazone and the Risk of Myocardial Infarction and Other Major Adverse Cardiac Events: A Meta-Analysis of Randomized, Controlled Trials
2008
Outcomes of Chronic Heart Failure
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Benatar | 243 | 61 | 29 | 65 | 13 | 354 | |
| Rita Dale | 98 | 63 | 32 | 69 | 12 | 346 | |
| Cristina Peñaloza | 193 | 29 | 13 | 49 | 6 | 303 | |
| Jerry Murphy | 304 | 92 | 58 | 36 | 14 | 384 | |
| Keane K. Lee | 180 | 93 | 34 | 43 | 19 | 345 | |
| Michael Urbich | 209 | 56 | 32 | 31 | 10 | 324 | |
| Holly L. Rimmasch | 155 | 91 | 14 | 53 | 11 | 383 | |
| Andrew Tonkin | 136 | 63 | 60 | 72 | 18 | 363 | |
| Stanford Mwasongwe | 143 | 52 | 11 | 35 | 17 | 358 | |
| Liane Porepa | 180 | 79 | 7 | 59 | 8 | 382 | |
| Eva Fhärm | 129 | 47 | 52 | 54 | 19 | 393 |
All Works
Loading papers...